N-acetylcysteine-pretreated human embryonic mesenchymal stem cell administration protects against bleomycin-induced lung injury

American Journal of the Medical Sciences

Volumn 346, Issue 2, 2013, Pages 113-122

  Wang, Qiao ^a   Zhu, Hong ^a   Zhou, Wu Gang ^a   Guo, Xiao Can ^b   Wu, Min Juan ^b   Xu, Zhen Yu ^b   Jiang, Jun Feng ^b   Shen, Ce ^a   Liu, Hou Qi ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cell based treatment; Human embryonic mesenchymal stem cell; Lung injury; N acetylcysteine

Indexed keywords

ACETYLCYSTEINE; BLEOMYCIN; GLUTATHIONE; HYDROXYPROLINE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL ADHESION; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG FIBROSIS; LUNG INJURY; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PNEUMONIA; SURVIVAL RATE;

EID: 84880779281     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e318266e8d8     Document Type: Article

References (39)

1. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342:1334-49.
2. MacCallum NS, Evans TW. Epidemiology of acute lung injury. Curr Opin Crit Care 2005;11:43-9.
3. Calfee CS, Matthay MA. Nonventilatory treatments for acute lung injury and ARDS. Chest 2007;131:913-20.
4. Cepkova M, Matthay MA. Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome. J Intensive Care Med 2006;21: 119-43.
5. Gotts JE, Matthay MA. Mesenchymal stem cells and acute lung injury. Crit Care Clin 2011;27:719-33.
6. Dushianthan A, Grocott MP, Postle AD, et al. Acute respiratory distress syndrome and acute lung injury. Postgrad Med J 2011;87: 612-22.
7. Lee JW, Fang X, Krasnodembskaya A, et al. Concise review: mesenchymal stem cells for acute lung injury: role of paracrine soluble factors. Stem Cells 2011;29:913-9.
8. Song H, Song BW, Cha MJ, et al. Modification of mesenchymal stem cells for cardiac regeneration. Expert Opin Biol Ther 2010;10: 309-19.
9. Guo J, Lin G, Bao C, et al. Insulin-like growth factor 1 improves the efficacy of mesenchymal stem cells transplantation in a rat model of myocardial infarction. J Biomed Sci 2008;15:89-97.
10. Aguilar S, Scotton CJ, McNulty K, et al. Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis. PLoS One 2009;4: e8013.
11. Yang J, Zhou W, Zheng W, et al. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction. Cardiology 2007;107:17-29.
12. Drowley L, Okada M, Beckman S, et al. Cellular antioxidant levels influence muscle stem cell therapy. Mol Ther 2010;18:1865-73.
13. Song H, Cha MJ, Song BW, et al. Reactive oxygen species inhibit adhesion of mesenchymal stem cells implanted into ischemic myocardium via interference of focal adhesion complex. Stem Cells 2010;28: 555-63.
14. Ward PA. Oxidative stress: acute and progressive lung injury. Ann N Y Acad Sci 2010;1203:53-9.
15. Goto H, Ledford JG, Mukherjee S, et al. The role of surfactant protein A in bleomycin-induced acute lung injury. Am J Respir Crit Care Med 2010;181:1336-44.
16. Rhee CK, Lee SH, Yoon HK, et al. Effect of nilotinib on bleomycininduced acute lung injury and pulmonary fibrosis in mice. Respiration 2011;82:273-87.
17. Wu M, Yang L, Liu S, et al. Differentiation potential of human embryonic mesenchymal stem cells for skin-related tissue. Br J Dermatol 2006;155:282-91.
18. van de Loosdrecht AA, Beelen RH, Ossenkoppele GJ, et al. A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia. J Immunol Methods 1994;174:311-20.
19. Jakubowski W, Bartosz G. 2,7-dichlorofluorescin oxidation and reactive oxygen species: what does it measure? Cell Biol Int 2000;24:757-60.
20. Smith MR, Gangireddy SR, Narala VR, et al. Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2010; 298:L616-25.
21. Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 1988; 41:467-70.
22. Tanino Y, Makita H, Miyamoto K, et al. Role of macrophage migration inhibitory factor in bleomycin-induced lung injury and fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2002;283:L156-62.
23. Tanaka K, Ishihara T, Azuma A, et al. Therapeutic effect of lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2010;298:L348-60.
24. Metrailler-Ruchonnet I, Pagano A, Carnesecchi S, et al. Bcl-2 overexpression in type II epithelial cells does not prevent hyperoxia-induced acute lung injury in mice. Am J Physiol Lung Cell Mol Physiol 2010; 299:L312-22.
25. Yang YS, Yang MC, Guo Y, et al. PLAGL2 expression-induced lung epithelium damages at bronchiolar alveolar duct junction in emphysema: bNip3-and SP-C-associated cell death/injury activity. Am J Physiol Lung Cell Mol Physiol 2009;297:L455-66.
26. Yuan L, Wu MJ, Sun HY, et al. VEGF-modified human embryonic mesenchymal stem cell implantation enhances protection against cisplatin-induced acute kidney injury. Am J Physiol Renal Physiol 2011; 300:F207-18.
27. O'Donoghue K, Fisk NM. Fetal stem cells. Best Pract Res Clin Obstet Gynaecol 2004;18:853-75.
28. Sukhikh GT, Malaitsev VV, Bogdanova IM. Application potential of human fetal stem/progenitor cells in cell therapy. Bull Exp Biol Med 2008;145:114-21.
29. Gotherstrom C, Ringden O, Tammik C, et al. Immunologic properties of human fetal mesenchymal stem cells. Am J Obstet Gynecol 2004;190:239-45.
30. Izbicki G, Segel MJ, Christensen TG, et al. Time course of bleomycin-induced lung fibrosis. Int J Exp Pathol 2002;83:111-9.
31. Mei SH, McCarter SD, Deng Y, et al. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 2007;4:e269.
32. Rojas M, Xu J, Woods CR, et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2005; 33:145-52.
33. Kotton DN, Fabian AJ, Mulligan RC. Failure of bone marrow to reconstitute lung epithelium. Am J Respir Cell Mol Biol 2005;33:328-34.
34. Mossman BT. Introduction to serial reviews on the role of reactive oxygen and nitrogen species (ROS/RNS) in lung injury and diseases. Free Radic Biol Med 2003;34:1115-6.
35. Hagiwara SI, Ishii Y, Kitamura S. Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice. Am J Respir Crit Care Med 2000;162:225-31.
36. Zhu WG, Li S, Lin LQ, et al. Vascular oxidative stress increases dendritic cell adhesion and transmigration induced by homocysteine. Cell Immunol 2009;254:110-6.
37. Kotton DN, Ma BY, Cardoso WV, et al. Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development 2001;128:5181-8.
38. Block GJ, Ohkouchi S, Fung F, et al. Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1. Stem Cells 2009;27:670-81.
39. Zhen G, Xue Z, Zhao J, et al. Mesenchymal stem cell transplantation increases expression of vascular endothelial growth factor in papaininduced emphysematous lungs and inhibits apoptosis of lung cells. Cytotherapy 2010;12:605-14.